Patent details

Basic Information

Publication number:

EP2517718

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP120054556

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Treatment of T-cell mediated diseases

French Title of Invention:

Traitement de maladies à mediation des lymphocytes T

German Title of Invention:

Behandlung von T-Zell-vermittelten Krankheiten

SPC Number:

Dates

Filing date:

14/05/2004

Grant date:

02/03/2016

EP Publication Date:

02/03/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

31/10/2012

EP B1 Publication Date:

02/03/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/05/2016

Expiration date:

14/05/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/05/2004

 

 

Name:

Ampio Pharmaceuticals Inc.

Address:

373 Inverness Parkway Suite 200, Englewood, CO 80112, United States (US)

Inventor

1

Name:

Shimonkevitz Richard

Address:

United States (US)

2

Name:

Bar-Or Raphael

Address:

United States (US)

3

Name:

Bar-Or David

Address:

United States (US)

Priority

1

Priority Number:

471017 P

Priority Date:

15/05/2003

Priority Country:

United States (US)

2

Priority Number:

489270 P

Priority Date:

21/07/2003

Priority Country:

United States (US)

3

Priority Number:

514930 P

Priority Date:

27/10/2003

Priority Country:

United States (US)

4

Priority Number:

517338 P

Priority Date:

04/11/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61P 37/06;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages